Letters FGM Enhanced Data Collection

Mandatory submission of patient identifiable information to third parties: FGM now, what next?

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5146 (Published 30 September 2015) Cite this as: BMJ 2015;351:h5146
  1. Susan Bewley, professor of complex obstetrics1,
  2. Brenda Kelly, consultant obstetrician and clinical lead for the Oxford Rose Clinic2,
  3. Katrina Darke, general practitioner and clinical lead for the Bristol Community Rose Clinic3,
  4. Katrina Erskine, consultant obstetrician and gynaecologist and associate medical director4,
  5. Clare Gerada, general practitioner5,
  6. Patricia Lohr, medical director6,
  7. Paquita de Zulueta, honorary senior clinical lecturer7
  1. 1Women’s Health Academic Centre, St Thomas’ Hospital, London SE1 7EH, UK
  2. 2Oxford University Hospitals NHS Trust, Oxford, UK
  3. 3Lawrence Hill Health Centre, Bristol, UK
  4. 4Homerton University Hospital, London
  5. 5Hurley Clinic, London
  6. 6British Pregnancy Advisory Service, London
  7. 7Department of Public Health and Primary Care, Imperial College London, London
  1. susan.bewley{at}kcl.ac.uk

The government has done much to tackle female genital mutilation (FGM),1 2 3 but the planned rollout of FGM Enhanced Data Collection across the NHS in October 2015 is ill considered. All healthcare professionals will be legally obliged to submit highly sensitive, patient identifiable information on every woman with FGM attending the NHS for whatever reason. A woeful consultation preceded the ministerial direction, which also says patient consent is not …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe